LAS VEGAS (FOX5) — A Las Vegas hospital has achieved a major milestone as staff celebrates the completion of its 100th stem cell transplant.
The Sarah Cannon Transplant and Cellular Therapy Program at MountainView Hospital is the first of its kind in the state to offer advanced blood cancer treatment, and was launched in 2025.
“Reaching our 100th transplant is a significant milestone and powerful reminder of why this program was created,” said MountainView Hospital Chief Executive Officer Alexis Mussi. “Patients no longer have to travel out of state for highly complex, life-saving blood cancer care. They can now receive world-class treatment right here at home, surrounded by their families and support systems.”
In 2024, more than 1,200 patients left the state for inpatient cancer care. In 2025, prior to the program’s launch, 132 patients with various types of blood cancers had to travel out of state for care.
MORE: Pregnant Las Vegas mom battles rare blood cancer, hopes to save unborn child
“Stem cell transplants—both autologous and allogeneic—are among the most effective therapies we have for treating and, in many cases, curing blood cancers,” said Dr. Carolyn Mulroney, medical director of the Sarah Cannon Transplant & Cellular Therapy Program. “Having these treatments available in Nevada removes a significant barrier to care for patients who previously had no choice but to leave the state.”
The program offers various levels and types of care for patients with blood cancers, including autologous stem cell transplants, allogeneic stem cell transplants and CAR T-cell therapy, a cutting-edge immunotherapy that uses a patient’s own genetically modified immune cells to target cancer.
ONLY ON FOX5: Mom fights cancer after baby’s birth, pair return home to Las Vegas after 442 days in hospital
“Our network sees 130,000 newly diagnosed cancer patients annually, and our specialty provider leadership teams meet frequently to review and revise cancer treatment pathways and incorporate the latest research data to provide the best outcomes,” said Tom Cronin, regional vice president of oncology services for the Sarah Cannon Cancer Network.
Last summer, a doctor at the hospital explained that at least half of patients who could benefit from these therapies, like those with leukemia, aren’t able to leave the state for care. Those that do face tremendous challenges.
Patients and physicians who want to learn more about MountainView’s program can call (702) 962-2106 or visit SunriseHealthInfo.com/SarahCannon.
Copyright 2026 KVVU. All rights reserved.
